Inhibikase Therapeutics
IKT
#8376
Rank
HK$2.56 B
Marketcap
HK$18.39
Share price
-2.70%
Change (1 day)
N/A
Change (1 year)

Revenue for Inhibikase Therapeutics (IKT)

Revenue in 2026 (TTM): N/A

In 2025 the company made a revenue of N/A a decrease over the revenue in the year 2024 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Inhibikase Therapeutics from 2019 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) N/A
2025 N/A
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A